S&P 500 7,739 +5.78% Nasdaq 26,451 +8.22% Dow Jones 54,556 +5.74% FTSE 100 10,888 -0.18% DAX 26,126 +2.62% Nikkei 225 66,300 +7.17% Hang Seng 25,916 +0.42% WTI Crude 74.64 -11.85% Gold 4,309 +6.43% US 10-Year Treasury Yield 4.615 -1.03% S&P 500 7,739 +5.78% Nasdaq 26,451 +8.22% Dow Jones 54,556 +5.74% FTSE 100 10,888 -0.18% DAX 26,126 +2.62% Nikkei 225 66,300 +7.17% Hang Seng 25,916 +0.42% WTI Crude 74.64 -11.85% Gold 4,309 +6.43% US 10-Year Treasury Yield 4.615 -1.03%

LATEST

China’s copper smelting grip worries veteran metallurgist●Rocket Lab landed a $397 million U.S. Space Force contract for surveillance satellites●Tanger says World Cup tourism surged traffic and sales at its outlet centers●Uber and Wayve won London approval to start supervised self-driving rides this summer●SpaceX draws retail investors despite fall in shares post earnings●Soriot should explain the curious case of AstraZeneca’s non-deal●Disney is exploring a free, ad-supported streaming service and has sold out Super Bowl ads●Russia Passes Law to Regulate Crypto Exchanges, Keeps Payment Ban in Place●China’s copper smelting grip worries veteran metallurgist●Rocket Lab landed a $397 million U.S. Space Force contract for surveillance satellites●Tanger says World Cup tourism surged traffic and sales at its outlet centers●Uber and Wayve won London approval to start supervised self-driving rides this summer●SpaceX draws retail investors despite fall in shares post earnings●Soriot should explain the curious case of AstraZeneca’s non-deal●Disney is exploring a free, ad-supported streaming service and has sold out Super Bowl ads●Russia Passes Law to Regulate Crypto Exchanges, Keeps Payment Ban in Place●

Wealth

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

MarketWatch.com - Top Stories · 1h ago

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Read the full story at MarketWatch.com - Top Stories →

More Wealth

Alphabet’s stock drops as Google loses another key AI executive

MarketWatch.com - Top Stories · 1h ago

Affordability is a 'defining challenge' for Americans, with food costs leading the way, report finds

Personal Finance · 1h ago

5 things investors should know about the stock market’s latest rapid-fire comeback

MarketWatch.com - Top Stories · 2h ago

SpaceX’s stock falls as Wall Street gets spooked by the extent of AI spending

MarketWatch.com - Top Stories · 2h ago